Published in J Am Geriatr Soc on October 01, 1991
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother (1994) 3.73
Antibiotic treatment and survival of nursing home patients with lower respiratory tract infection: a cross-national analysis. Ann Fam Med (2005) 1.02
Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis (2004) 0.84
Sequential antibiotic therapy: Effective cost management and patient care. Can J Infect Dis (1995) 0.83
Treatment of nursing home-acquired pneumonia. J Am Geriatr Soc (1991) 0.75
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae. Antimicrob Agents Chemother (1981) 11.11
What is a mental/psychiatric disorder? From DSM-IV to DSM-V. Psychol Med (2010) 4.33
Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates. Antimicrob Agents Chemother (1982) 3.99
Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria. J Immunol Methods (1977) 3.89
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry (2008) 3.81
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42
Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun (1978) 3.23
Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes. J Infect Dis (1977) 3.09
Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol (1992) 2.92
The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest (1978) 2.83
Effect of protein A on staphylococcal opsonization. Infect Immun (1977) 2.79
Twelve-month mental disorders in South Africa: prevalence, service use and demographic correlates in the population-based South African Stress and Health Study. Psychol Med (2007) 2.55
Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med (1984) 2.52
Self-disclosure of HIV serostatus in recently diagnosed patients with HIV in South Africa. Afr J Reprod Health (2004) 2.31
Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect Immun (1979) 2.17
Multicenter comparative evaluation of two rapid microscopic methods and culture for detection of Chlamydia trachomatis in patient specimens. J Clin Microbiol (1988) 2.12
Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord (2007) 2.12
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09
Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am J Pathol (1985) 2.08
Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet (1986) 2.07
Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis. Infect Immun (1979) 2.07
Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun (1978) 2.03
Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. J Immunol (1982) 2.02
Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis (1979) 1.97
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97
A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med (1996) 1.96
Domestic violence in patients visiting general practitioners--prevalence, phenomenology, and association with psychopathology. S Afr Med J (1999) 1.92
Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun (1977) 1.92
Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun (1995) 1.91
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry (2001) 1.86
Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections. J Infect Dis (1981) 1.83
Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest (1981) 1.82
Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. J Clin Pathol (1978) 1.80
Trichobezoars in trichotillomania: case report and literature overview. Psychosom Med (1998) 1.69
Trichotillomania: behavioral symptom or clinical syndrome? Am J Psychiatry (1997) 1.63
Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes. Infect Immun (1976) 1.63
Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group. Br J Psychiatry (1999) 1.62
Human microglial cell defense against Toxoplasma gondii. The role of cytokines. J Immunol (1994) 1.61
Post-traumatic stress disorder among recently diagnosed patients with HIV/AIDS in South Africa. AIDS Care (2005) 1.60
Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am J Pathol (1987) 1.57
Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J Clin Psychiatry (1995) 1.57
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect Immun (1978) 1.56
Are musical obsessions a temporal lobe phenomenon? J Neuropsychiatry Clin Neurosci (1999) 1.56
Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains. Infect Immun (1979) 1.55
Association of panic disorder with a history of traumatic suffocation. Am J Psychiatry (1997) 1.54
Bacterial rep- mutations that block development of small DNA bacteriophages late in infection. J Virol (1976) 1.53
Eating disorder and superior mesenteric artery syndrome. J Am Acad Child Adolesc Psychiatry (2000) 1.52
Predictors of major depression in recently diagnosed patients with HIV/AIDS in South Africa. AIDS Patient Care STDS (2004) 1.50
Mental health and sexual risk behaviours in a South African township: a community-based cross-sectional study. Public Health (2006) 1.50
Isolation of protease-proficient, recombinase-deficient recA mutants of Escherichia coli K-12. J Bacteriol (1985) 1.49
Cognitive slowing and working memory difficulties in chronic fatigue syndrome. Psychosom Med (1997) 1.49
Clinical pharmacokinetics of ciprofloxacin. Clin Pharmacokinet (1990) 1.48
Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J Neurovirol (2001) 1.47
Violence in male patients with schizophrenia: risk markers in a South African population. Aust N Z J Psychiatry (2004) 1.47
Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes. J Infect Dis (1981) 1.46
Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin. Infect Immun (1980) 1.44
Povidone iodine and skin disinfection before initiation of epidural anesthesia. Anesthesiology (1998) 1.44
Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin Immunol Immunopathol (1993) 1.44
Trauma exposure and post-traumatic stress symptoms in urban African schools. Survey in CapeTown and Nairobi. Br J Psychiatry (2004) 1.43
Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factors. J Am Geriatr Soc (1993) 1.40
Characteristics and phenomenology of hair-pulling: an exploration of subtypes. Compr Psychiatry (2001) 1.40
Human polymorphonuclear leucocyte receptors for staphylococcal opsonins. Immunology (1977) 1.40
Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine (1991) 1.40
Maternal separation in rats leads to anxiety-like behavior and a blunted ACTH response and altered neurotransmitter levels in response to a subsequent stressor. Metab Brain Dis (2004) 1.40
'Sleep therapy' or medical malpractice? S Afr Med J (1997) 1.39
Selective serotonin reuptake inhibitors in children and adolescents. S Afr Med J (2006) 1.38
Complement-mediated phagocytosis of Pseudomonas aeruginosa. J Lab Clin Med (1978) 1.37
Isolation of Chlamydia trachomatis from the lower respiratory tract of adults. Lancet (1980) 1.37
Determinants of unprotected sex among HIV-positive patients in South Africa. AIDS Care (2005) 1.36
Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids. J Clin Microbiol (1984) 1.36
Phagocytosis by polymorphonuclear leukocytes of Staphylococcus aureus and Pseudomonas aeruginosa adherent to plastic, agar, or glass. J Immunol Methods (1983) 1.36
Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis (1983) 1.35
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique. Antimicrob Agents Chemother (1993) 1.34
Complement in endotoxin shock: effect of complement depletion on the early hypotensive phase. Infect Immun (1970) 1.34
Pharmacokinetics of cefepime in subjects with renal insufficiency. Clin Pharmacol Ther (1990) 1.32
Twelve-month treatment of psychiatric disorders in the South African Stress and Health Study (World Mental Health Survey Initiative). Soc Psychiatry Psychiatr Epidemiol (2008) 1.32
Tumor necrosis factor-alpha is a potent ACTH secretagogue: comparison to interleukin-1 beta. Endocrinology (1989) 1.31
Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J Infect Dis (1992) 1.31
Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients. Am J Med (1987) 1.30
Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int (1984) 1.29
Bacterial surface components and the pathogenesis of infectious diseases. Annu Rev Med (1981) 1.28
Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin. Antimicrob Agents Chemother (1990) 1.28
tif-dependent induction of colicin E1, prophage lambda, and filamentation in Escherichia coli K-12. J Bacteriol (1980) 1.28
Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation (2000) 1.27
Roles of RecA protease and recombinase activities of Escherichia coli in spontaneous and UV-induced mutagenesis and in Weigle repair. J Bacteriol (1986) 1.26
The Truth and Reconciliation Commission in South Africa: relation to psychiatric status and forgiveness among survivors of human rights abuses. Br J Psychiatry (2001) 1.26
Human phagocyte interactions with the Lyme disease spirochete. Infect Immun (1984) 1.25
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview. Diagn Microbiol Infect Dis (1992) 1.24
Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients. J Infect Dis (1984) 1.24
Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency. Antimicrob Agents Chemother (1986) 1.23
Classification of type III (severe) open fractures relative to treatment and results. Orthopedics (1987) 1.23
Factors affecting complement activation by Staphylococcus aureus cell walls, their components, and mutants altered in teichoic acid. Infect Immun (1981) 1.22
Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies. J Immunol (1980) 1.21
Immunodeficiency of the elderly. Rev Infect Dis (1988) 1.21
Follow-up results of distal coronary artery bypass for ischemic heart disease. Am J Cardiol (1972) 1.20
A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry (1997) 1.19
Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis (1987) 1.19